The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma

Histopathology

Volumn 42, Issue 3, 2003, Pages 217-226

  Rajpert De Meyts, Ewa ^a,e   Jacobsen, G K ^b   Bartkova, J ^c   Aubry, F ^d   Samson, M ^d   Bartek, J ^c   Skakkebaek N E ^a  

^a Mental Health Services CPH   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d UNIVERSITÉ DE RENNES 1   (France)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chk2; Germ cell; MAGE A4; Neurone specific enolase; p19INK4d; p53; Spermatocytic seminoma; Testicular neoplasm

Indexed keywords

ALKALINE PHOSPHATASE; CHECKPOINT KINASE 2; MELANOMA ANTIGEN 4; NEURON SPECIFIC ENOLASE; ONCOFETAL ANTIGEN; PROTEIN; PROTEIN P19; PROTEIN P53; PROTEIN TRA 1 60; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPAIR; EMBRYO; EMBRYO CELL; EVIDENCE BASED MEDICINE; FETUS; GERM CELL; GERM CELL TUMOR; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEIOSIS; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; SEMINOMA; SPERMATOGONIUM; TESTIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P19; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PHOSPHOPYRUVATE HYDRATASE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SEMINOMA; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037343516     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2003.01587.x     Document Type: Article

References (46)

1. Masson P. Étude sur le séminome. Rev. Can. Biol. 1946: 5; 361-387.
2. Skakkebæk NE. Possible carcinoma-in-situ of the testis. Lancet 1972: 2; 516-517.
3. Ulbright TM, Amin MB, Young RH. Tumors of the testis, adnexa, spermatic cord and scrotum. Fascicle 25. In Rosai J, Sobin LH eds. Atlas of tumor pathology. Third Series. Washington DC: Armed Forces Institute of Pathology. 1999: 1-385.
4. Skakkebæk NE, Berthelsen JG, Giwercman A, Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int. J. Androl. 1987: 10; 19-28.
5. Müller J, Skakkebæk NE, Constance Parkinson M. The spermatocytic seminoma: views on pathogenesis. Int. J. Androl. 1987: 10; 147-156.
6. Talerman A. Spermatocytic seminoma. Clinicopathologic study of 22 cases. Cancer 1980: 45; 2169-2176.
7. Eble JN. Spermatocytic seminoma. Hum. Pathol. 1994: 25; 1035-1042.
8. Rosai J, Khodadoust K, Silber I. Spermatocytic seminoma. I. Clinicopathologic study of six cases and review of literature. II. Ultrastructural study. Cancer 1969: 24; 92-116.
9. Dekker I, Rozeboom T, Delemarre J, Dam ABS, Oosterhuis JW. Placental-like alkaline phosphatase and DNA flow cytometry in spermatocytic seminoma. Cancer 1992: 69; 993-996.
10. Kraggerud SM, Berner A, Bryne M, Petersen EO, Fosså SD. Spermatocytic seminoma as compared to classical seminoma. An immunohistochemical and DNA flow cytometric study. APMIS 1999: 107; 297-302.
11. Talerman A, Fu YS, Okagaki T. Spermatocytic seminoma. ultrastructural and microspectrophotometric observations. Lab. Invest. 1984: 51; 343-349.
12. Rosenberg C, Mostert MC, Schut TB et al. Chromosomal constitution of human spermatocytic seminomas: comparative genomic hybridization supported by conventional and interphase cytogenetics. Genes Chromosomes Cancer 1998: 23; 286-291.
13. Romanenko AM, Persidsky YV, Mostofi FK. Ultrastructure and histogenesis of spermatocytic seminoma. J. Urol. Pathol. 1993: 1; 387-395.
14. Rudolph P, Kellner U, Schmidt D et al. Ki-A10, a germ cell nuclear antigen retained in a subset of germ cell-derived tumors. Am. J. Pathol. 1999: 154; 795-803.
15. Stoop H, van Gurp R, de Krijger R et al. Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab. Invest. 2001: 81; 919-928.
16. INK4d in human testicular germ cell tumours contrasts with high expression during normal spermatogenesis. Oncogene 2000: 19; 4146-4150.
17. Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, Bartek J. Chk2 tumour suppressor protein in human spermatogenesis and testicular germ cell tumours. Oncogene 2001: 20; 5897-5902.
18. Levine AJ. P53, the cellular gate keeper for growth and division. Cell 1997: 88; 323-331.
19. Bartkova J, Bartek J, Lukas J et al. p53 protein alterations in human testicular cancer including pre-invasive intratubular germ cell neoplasia. Int. J. Cancer 1991: 49; 196-202.
20. Lutzker SG. P53 tumour suppressor gene and germ cell neoplasia. APMIS 1998: 106; 85-89.
21. Hara I, Hara S, Miyake H et al. Expression of MAGE genes in testicular germ cell tumors. Urology 1999: 53; 843-847.
22. Jungbluth AA, Busam KJ, Kolb D et al. Expression of MAGE-antigens in normal tissues and cancer. Int. J. Cancer 2000: 85; 460-465.
23. Aubry F, Satie AP, Rioux-Leclercq N et al. MAGE-A4. a germ cell specific marker is differentially expressed in testicular tumours. Cancer 2001: 92; 2778-2785.
24. Kang J-L, Rajpert-De Meyts E, Skakkebæk NE. Immunoreactive neuron-specific enolase (NSE) is expressed in testicular carcinoma in situ. J. Pathol. 1996: 178; 161-165.
25. Giwercman A, Andrews PW, Jørgensen N, Müller J, Græm N, Skakkebæk NE. Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumours of the testis. Cancer 1993: 72; 1308-1314.
26. Strohmeyer T, Peter S, Hartmann M et al. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res. 1991: 51; 1811-1816.
27. Rajpert-De Meyts E, Skakkebæk NE. Expression of the c-kit protein product in carcinoma in situ and invasive germ cell tumours. Int. J. Androl. 1994: 17; 85-92.
28. Beckstead JH. Alkaline phosphatase histochemistry in human germ cell neoplasms. Am. J. Surg. Pathol. 1983: 7; 341-349.
29. Jacobsen GK, Nørgaard-Pedersen B. Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. Acta Pathol. Microbiol. Scand. A 1984: 92; 323-329.
30. Thullberg M, Welcker M, Bartkova J et al. Monoclonal antibody probes for p21WAF1/CIP1 and the INK4 family of cyclin-dependent kinase inhibitors. Hybridoma 2000: 19; 63-72.
31. Andrews PW, Banting GS, Damjanov I, Arnaud D, Avner P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 1984: 3; 347-361.
32. Tapia FJ, Polak JM, Barbosa AJA, Bloom SR, Marangos PJ, Dermody C. Neuron-specific enolase is produced by neuroendocrine tumour. Lancet 1981: 11; 808-811.
33. Cummings OW, Ulbright TM, Eble JN, Roth LM. Spermatocytic seminoma: an immunohistochelnical study. Hum. Pathol. 1994: 25; 54-59.
34. Jørgensen N, Rajpert-De Meyts E, Græm N, Müller J, Giwercman A, Skakkebæk NE. Expression of immunohistochemical markers for testicular carcinoma-in situ by normal human fetal germ cells. Lab. Invest. 1995: 72; 223-231.
35. Burke AP, Mostofi FK. Spermatocytic seminoma. A clinicopathologic study of 79 cases. J. Urol. Pathol. 1993: 1; 21-32.
36. Van den Eynde B, van der Bruggen P. T cell-defined tumor antigens. Curr. Opin. Immunol. 1997: 9; 684-693.
37. Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of the testis. Cancer Res. 1995: 55; 3478-3482.
38. Satie A-P, Rajpert-De Meyts E, Spagnoli GC et al. The cancer-testis gene NY-ESO-1 is expressed in normal fetal and adult testes, in spermatocytic seminoma and testicular carcinoma in situ. Lab. Invest. 2002: 82; 775-780.
39. Quenby SM, Gazvani MR, Brazeau C, Neilson J, Lewis-Jones DI, Vince G. Oncogenes and tumour suppressor genes in first trimester human fetal gonadal development. Mol. Hum. Reprod. 1999: 5; 737-741.
40. Albores-Saavedra J, Huffman H, Alvarado-Cabrero I, Ayala AG. Anaplastic variant of spermatocytic seminomas. Hum. Pathol. 1996: 27; 650-655.
41. Matsuoka S, Huang M, Elledge S. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998: 282; 1893-1897.
42. Bartek J, Falck J, Lukas J. Chk2 kinase - a busy messenger. Nature Rev. Mol. Cell. Biol. 2001: 2; 877-886.
43. Zindy F, van Deursen J, Grosveld G, Sherr CJ, Roussel MF. INK4d-deficient mice are fertile despite testicular atrophy. Mol. Cell. Biol. 2000: 20; 372-378.
44. INK4d. Mol. Cell. Biol. 2001: 21; 3244-3255.
45. Lee M-C, Talerman A, Oosterhuis JW, Damjanov I. Lectin histochemistry of classic and spermatocytic seminoma. Arch. Pathol. Lab. Med. 1985: 109; 938-942.
46. Zeeman AM, Stoop H, Boter M et al. VASA is a specific marker for both normal and malignant human germ cells. Lab. Invest. 2002: 83; 159-166.